The 4th edition of the Cardio Vascular Conference 2014 took place the 6th and 7th of March in the Heerlickheijd in Ermelo, the Netherlands.

Programme CVC 2014

Donderdag 6 maart 2014

09.55           Opening 4th Cardio Vascular ConferenceProf. Wouter Jukema, Leiden
Paradigm shifts in pathogenesis and Therapy (DEBS session)
10.00-10.30
Turning up the heat: brown adipose tissue as a new target in metabolic disease
Patrick Rensen, Leiden
10.30-11.00 The endothelial angiopoietin/Tie2 system in micro vascular diseases
Sascha David, Hannover
11.00-11.30 Attenuation of inflammation to cure cardiometabolic disease:
Time for clinical implementation?
Tom Seijkens, Amsterdam
11.30-12.15 Targeting endothelial matabolism: principles and strategies
Peter Carmeliet, Leuven
12.15-13.30 Moderated poster sessions, lunch & exhibition
13.30-15.30 Parallel: Innovative Industry Discussion Sessions
Vascular Complications in non-vascular diseases
13.30-14.00 Vascular risk management in oncology patients after chemotherapy
Joop Lefrandt, UMCG, Groningen
14.00-14.30 Vascular risk management in Rheumatoid patients with/without inflammatory activity
M Nurmohamed, VU, Amsterdam
14.30-15.00 Vascular risk management in HIV-patients with/without residual viral load
Mark van de Valk, AMC, Amsterdam
15.00-15.30 Tea break
Vasculaire casuistiek
15.30*16.00 Patient referred for risk management with a high CAC score: what now?
Raphael Duivenvoorden, AMC, Amsterdam
16.00-16.30 Capillary microscopy in systemic disease: Should vascular specialists have access to this technology?
Erik Serné, VUmc, Amsterdam
16.30-17.00 Brain-stem associated hypertension: Rare cases which should not be missed!?
Jaap Deinum, Radboudumc, Nijmegen
Visionary lecture CVD 2020
17.00-17.30 Epigenetic reprogramming: Role in inflammatory disease and atherosclerosis
Niels Riksen, Radboudumc,Nijmegen

Vrijdag 7 maart 2014

State of the art lectures
08.30-09.00 The diabetes-update quiz
Joost Hoekstra, AMC, Amsterdam
09.00-09.30 Imaging in the Rotterdam study: what have we learned and what will we learn?
Daniel Bos, ErasmusMC, Rotterdam
Practice changing within the next 2 years
09.30-10.00 Pleiotropics of renal denervation: Are benefits beyond BP lowering for real?
The story after SYMPLICITY HTN-3
Michiel Voskuil, UMCU, Utrecht
10.00-11.00 FH Clinical care 2014 (chairman Erik Stroes)
MTP inhibition (Eric Sijbrands)
Anti PCSK9 monoclonal antibodies (John Kastelein)
LEEFH - alive and kicking (Erik Stroes)
11.00-11.30 Coffee break & posters
Society sessions (per topic)
11.30-13.00 Society Parallel Sessions
13.00-13.45 Lunch break
Best abstract presentations
13.45-14.30 Presentation best abstracts
State of the art in CVD & atherosclerosis
14.30-15.00 Clinical update on hypertriglycerdemia: Where do we go from here?
Erik Stroes, AMC, Amsterdam
15.00-15.30 NOACs: first choice in the frail and elderly, other high-risk bleeding groups, only in other countries?
PW Kamphuisen, UMCG, Groningen
15.30-16.00 CVC 2014 awards